| Dr Houshang Shahim, MD | |
|
20 Plaza West, Cedarwood Hall, Valhalla, NY 10595-1681 | |
| (914) 493-8155 | |
| (914) 493-1973 |
| Full Name | Dr Houshang Shahim |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 20 Plaza West, Valhalla, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063636637 | NPI | - | NPPES |
| 02357817 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 161855 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Houshang Shahim, MD 505 E 79th St, Apt 14m, New York, NY 10075-0709 Ph: (914) 493-8155 | Dr Houshang Shahim, MD 20 Plaza West, Cedarwood Hall, Valhalla, NY 10595-1681 Ph: (914) 493-8155 |
News Archive
Six California-based institutions specializing in health, hospital, university and nonprofit health announced today the formation of a new and unprecedented collaboration effort to rescue, restructure, reinvigorate and guide Charles R. Drew University of Medicine and Science (CDU) towards a new, resurgent and financially viable future.
Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.
Walking may slow cognitive decline in adults with mild cognitive impairment (MCI) and Alzheimer's disease, as well as in healthy adults, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to a research published in the July issue of the journal Nature.
Building on research results published today in JAMA Neurology showing patients with larger ischemic strokes could benefit from endovascular thrombectomy, an international, multicenter Phase III clinical trial will be starting at The University of Texas Health Science Center at Houston.
› Verified 8 days ago
Richard G. Mccarrick, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 40 Sunshine Cottage Rd, New York Medical College, Administration Bldg. Room 143, Valhalla, NY 10595 Phone: 914-594-4503 Fax: 914-594-4565 | |
Joan R Youchah, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Behavioral Health Center N312, Valhalla, NY 10595 Phone: 914-493-7124 Fax: 914-493-1015 | |
Dr. Shakeeb Hussain, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 E Stevens Ave Ste 108, Valhalla, NY 10595 Phone: 845-471-1807 | |
Stuart Alex Brill, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 913-660-2683 | |
Santhi S Ratakonda, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 | |
Iqbal Q Sheikh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Nymc, Behavioral Health Center N312, Valhalla, NY 10595 Phone: 914-493-7124 Fax: 914-493-1015 |